| Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies. | |
| | |
MedLine Citation:
|
PMID: 20332643 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To investigate whether the maternal serum concentration of placental protein 13 (PP13) is altered in chromosomally abnormal pregnancies and to examine the potential value of this placental protein in screening for aneuploidies at 11-13 weeks. METHODS: The maternal serum concentration of PP13 at 11-13 weeks was compared in 536 euploid and 134 aneuploid pregnancies (trisomy 21: n = 49; trisomy 18: n = 28; trisomy 13: n = 19; Turner syndrome: n = 28; triploidy: n = 10). RESULTS: Serum PP13, expressed as multiples of the median (MoM) of the euploid group, was not significantly different in trisomy 21 (1.12 MoM) pregnancies, but the levels were decreased in trisomy 18 (0.75 MoM), trisomy 13 (0.65 MoM), Turner syndrome (0.61 MoM) and triploidy (0.19 MoM). In both euploid and aneuploid pregnancies there was a significant association of serum PP13 with both serum pregnancy-associated plasma protein A (PAPP-A) and free beta-human chorionic gonadotropin (beta-hCG; p < 0.0001 for both). Logistic regression analysis demonstrated that the addition of serum PP13 did not improve the prediction of trisomy 13 and 18 provided by a combination of maternal age, nuchal translucency, and serum free beta-hCG and PAPP-A. CONCLUSION: The measurement of maternal serum PP13 at 11-13 weeks does not improve the performance of screening for aneuploidies achieved by current algorithms. |
| | |
Authors:
|
Ranjit Akolekar; Jos? Mar?a P?rez Penco; Evdoxia Skyfta; Jes?s Rodr?guez Calvo; Kypros H Nicolaides |
Related Documents
:
|
17100203 - Prenatal diagnosis of mosaicism identified in amniotic fluid cell cultures. 15252723 - Trisomy 1 in a case of a missed abortion. 9099513 - Antibacterial therapy in pregnancy and neonates. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't Date: 2010-03-23 |
Journal Detail:
|
Title: Fetal diagnosis and therapy Volume: 27 ISSN: 1421-9964 ISO Abbreviation: Fetal. Diagn. Ther. Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-03-24 Completed Date: 2010-06-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9107463 Medline TA: Fetal Diagn Ther Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 72-7 Citation Subset: IM |
Copyright Information:
|
2010 S. Karger AG, Basel. |
Affiliation:
|
Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aneuploidy Case-Control Studies Chorionic Gonadotropin, beta Subunit, Human / blood Chromosome Aberrations* Chromosomes, Human, Pair 13 / genetics Chromosomes, Human, Pair 18 / genetics Down Syndrome / blood Female Galectins / blood* Gestational Age* Humans Nuchal Translucency Measurement Pregnancy Pregnancy Proteins / blood* Pregnancy-Associated Plasma Protein-A / analysis Prenatal Diagnosis / methods Trisomy / diagnosis Turner Syndrome / blood |
| Chemical | |
Reg. No./Substance:
|
0/Chorionic Gonadotropin, beta Subunit, Human; 0/Galectins; 0/LGALS13 protein, human; 0/Pregnancy Proteins; EC 3.4.24.-/Pregnancy-Associated Plasma Protein-A |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Significant expression of interleukin 15 in rat experimental severe acute pancreatitis.
Next Document: Endometrial polyps: symptomatology, menopausal status and malignancy.